Oncology Net Borrowings vs Begin Period Cash Flow Analysis

TOI Stock  USD 0.22  0.02  10.00%   
Oncology Institute financial indicator trend analysis is much more than just breaking down Oncology Institute prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Oncology Institute is a good investment. Please check the relationship between Oncology Institute Net Borrowings and its Begin Period Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.

Net Borrowings vs Begin Period Cash Flow

Net Borrowings vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Oncology Institute Net Borrowings account and Begin Period Cash Flow. At this time, the significance of the direction appears to have strong relationship.
The correlation between Oncology Institute's Net Borrowings and Begin Period Cash Flow is 0.64. Overlapping area represents the amount of variation of Net Borrowings that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Oncology Institute, assuming nothing else is changed. The correlation between historical values of Oncology Institute's Net Borrowings and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Borrowings of Oncology Institute are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Net Borrowings i.e., Oncology Institute's Net Borrowings and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.64
Relationship DirectionPositive 
Relationship StrengthSignificant

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from Oncology Institute's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Oncology Institute current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.The Oncology Institute's current Selling General Administrative is estimated to increase to about 121.1 M, while Tax Provision is forecasted to increase to (84.5 K).
 2021 2022 2023 2024 (projected)
Interest Expense320K4.1M6.8M7.1M
Depreciation And Amortization3.3M4.4M5.9M3.8M

Oncology Institute fundamental ratios Correlations

0.840.850.880.680.330.70.740.4-0.780.690.530.70.80.820.790.80.310.830.760.780.890.860.780.720.82
0.840.980.860.90.450.890.820.4-0.780.650.640.860.910.950.940.910.450.980.860.910.960.970.980.790.97
0.850.980.920.840.530.920.80.33-0.850.780.730.750.940.950.970.890.40.970.880.960.980.980.940.790.99
0.880.860.920.630.40.750.780.38-0.910.870.630.630.890.870.860.840.230.880.850.870.970.920.770.780.89
0.680.90.840.630.560.850.590.18-0.50.430.640.850.660.740.840.680.750.790.570.810.770.780.890.550.84
0.330.450.530.40.560.75-0.02-0.62-0.220.640.950.060.340.320.70.110.710.350.170.740.460.360.36-0.030.6
0.70.890.920.750.850.750.630.04-0.710.770.890.570.820.80.980.680.520.840.710.970.850.840.840.620.95
0.740.820.80.780.59-0.020.630.79-0.90.530.290.760.870.850.680.93-0.070.880.910.640.820.880.831.00.76
0.40.40.330.380.18-0.620.040.79-0.550.0-0.360.630.480.50.120.69-0.410.50.610.060.380.490.470.790.25
-0.78-0.78-0.85-0.91-0.5-0.22-0.71-0.9-0.55-0.83-0.52-0.54-0.9-0.83-0.77-0.850.06-0.85-0.9-0.77-0.88-0.87-0.72-0.92-0.82
0.690.650.780.870.430.640.770.530.0-0.830.830.220.740.650.820.550.190.670.660.860.810.710.520.550.8
0.530.640.730.630.640.950.890.29-0.36-0.520.830.210.580.530.860.350.590.570.430.890.670.590.540.280.79
0.70.860.750.630.850.060.570.760.63-0.540.220.210.680.790.630.840.420.810.680.580.740.80.90.710.7
0.80.910.940.890.660.340.820.870.48-0.90.740.580.680.980.890.950.10.980.980.860.940.980.90.870.94
0.820.950.950.870.740.320.80.850.5-0.830.650.530.790.980.880.970.20.990.960.840.950.990.950.830.93
0.790.940.970.860.840.70.980.680.12-0.770.820.860.630.890.880.770.490.910.790.990.930.910.880.660.99
0.80.910.890.840.680.110.680.930.69-0.850.550.350.840.950.970.770.080.970.970.730.910.960.930.910.85
0.310.450.40.230.750.710.52-0.07-0.410.060.190.590.420.10.20.490.080.25-0.050.510.330.250.4-0.120.42
0.830.980.970.880.790.350.840.880.5-0.850.670.570.810.980.990.910.970.250.950.870.961.00.970.860.95
0.760.860.880.850.570.170.710.910.61-0.90.660.430.680.980.960.790.97-0.050.950.760.90.950.870.90.86
0.780.910.960.870.810.740.970.640.06-0.770.860.890.580.860.840.990.730.510.870.760.930.890.830.630.98
0.890.960.980.970.770.460.850.820.38-0.880.810.670.740.940.950.930.910.330.960.90.930.980.90.80.96
0.860.970.980.920.780.360.840.880.49-0.870.710.590.80.980.990.910.960.251.00.950.890.980.950.860.96
0.780.980.940.770.890.360.840.830.47-0.720.520.540.90.90.950.880.930.40.970.870.830.90.950.790.92
0.720.790.790.780.55-0.030.621.00.79-0.920.550.280.710.870.830.660.91-0.120.860.90.630.80.860.790.74
0.820.970.990.890.840.60.950.760.25-0.820.80.790.70.940.930.990.850.420.950.860.980.960.960.920.74
Click cells to compare fundamentals

Oncology Institute Account Relationship Matchups

Oncology Institute fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding64.4M59.1M66.2M80.6M73.7M68.4M

Currently Active Assets on Macroaxis

When determining whether Oncology Institute offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncology Institute's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncology Institute Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncology Institute Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.77)
Revenue Per Share
4.873
Quarterly Revenue Growth
0.229
Return On Assets
(0.19)
Return On Equity
(1.26)
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.